Annual FCF
-$376.22 M
-$75.89 M-25.27%
December 31, 2024
Summary
- As of March 12, 2025, RXRX annual free cash flow is -$376.22 million, with the most recent change of -$75.89 million (-25.27%) on December 31, 2024.
- During the last 3 years, RXRX annual FCF has fallen by -$177.81 million (-89.62%).
- RXRX annual FCF is now -621.64% below its all-time high of -$52.13 million, reached on December 31, 2020.
Performance
RXRX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$117.08 M
-$53.29 M-83.55%
December 31, 2024
Summary
- As of March 12, 2025, RXRX quarterly free cash flow is -$117.08 million, with the most recent change of -$53.29 million (-83.55%) on December 31, 2024.
- Over the past year, RXRX quarterly FCF has dropped by -$53.29 million (-83.55%).
- RXRX quarterly FCF is now -260.28% below its all-time high of $73.05 million, reached on March 31, 2022.
Performance
RXRX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$376.22 M
-$40.58 M-12.09%
December 31, 2024
Summary
- As of March 12, 2025, RXRX TTM free cash flow is -$376.22 million, with the most recent change of -$40.58 million (-12.09%) on December 31, 2024.
- Over the past year, RXRX TTM FCF has dropped by -$40.58 million (-12.09%).
- RXRX TTM FCF is now -1933.51% below its all-time high of -$18.50 million, reached on March 31, 2020.
Performance
RXRX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
RXRX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -25.3% | -83.5% | -12.1% |
| 3 y3 years | -89.6% | -83.5% | -12.1% |
| 5 y5 years | -517.2% | -83.5% | -12.1% |
RXRX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -211.2% | at low | -260.3% | at low | -400.3% | at low |
| 5 y | 5-year | -621.6% | at low | -260.3% | at low | -1933.5% | at low |
| alltime | all time | -621.6% | at low | -260.3% | at low | -1933.5% | at low |
Recursion Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$376.22 M(+25.3%) | -$117.08 M(+83.5%) | -$376.22 M(+12.1%) |
| Sep 2024 | - | -$63.79 M(-26.2%) | -$335.63 M(-2.9%) |
| Jun 2024 | - | -$86.40 M(-20.7%) | -$345.60 M(+4.5%) |
| Mar 2024 | - | -$108.95 M(+42.4%) | -$330.63 M(+10.1%) |
| Dec 2023 | -$300.33 M(+148.4%) | -$76.49 M(+3.7%) | -$300.33 M(+8.6%) |
| Sep 2023 | - | -$73.75 M(+3.2%) | -$276.56 M(+4.0%) |
| Jun 2023 | - | -$71.44 M(-9.2%) | -$265.92 M(-2.4%) |
| Mar 2023 | - | -$78.66 M(+49.2%) | -$272.58 M(+125.5%) |
| Dec 2022 | -$120.88 M | -$52.73 M(-16.4%) | -$120.88 M(-9.6%) |
| Sep 2022 | - | -$63.10 M(-19.2%) | -$133.78 M(+17.9%) |
| Jun 2022 | - | -$78.10 M(-206.9%) | -$113.43 M(+50.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $73.05 M(-211.3%) | -$75.19 M(-62.1%) |
| Dec 2021 | -$198.41 M(+280.6%) | -$65.62 M(+53.5%) | -$198.41 M(+54.0%) |
| Sep 2021 | - | -$42.75 M(+7.2%) | -$128.81 M(+21.1%) |
| Jun 2021 | - | -$39.87 M(-20.5%) | -$106.34 M(+26.9%) |
| Mar 2021 | - | -$50.17 M(-1359.9%) | -$83.80 M(+60.7%) |
| Dec 2020 | -$52.13 M(-14.5%) | - | - |
| Dec 2020 | - | $3.98 M(-119.6%) | -$52.13 M(-7.1%) |
| Sep 2020 | - | -$20.28 M(+17.0%) | -$56.12 M(+56.6%) |
| Jun 2020 | - | -$17.33 M(-6.3%) | -$35.83 M(+93.7%) |
| Mar 2020 | - | -$18.50 M | -$18.50 M |
| Dec 2019 | -$60.95 M | - | - |
FAQ
- What is Recursion Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals annual FCF year-on-year change?
- What is Recursion Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals quarterly FCF year-on-year change?
- What is Recursion Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals TTM FCF year-on-year change?
What is Recursion Pharmaceuticals annual free cash flow?
The current annual FCF of RXRX is -$376.22 M
What is the all time high annual FCF for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high annual free cash flow is -$52.13 M
What is Recursion Pharmaceuticals annual FCF year-on-year change?
Over the past year, RXRX annual free cash flow has changed by -$75.89 M (-25.27%)
What is Recursion Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of RXRX is -$117.08 M
What is the all time high quarterly FCF for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high quarterly free cash flow is $73.05 M
What is Recursion Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, RXRX quarterly free cash flow has changed by -$53.29 M (-83.55%)
What is Recursion Pharmaceuticals TTM free cash flow?
The current TTM FCF of RXRX is -$376.22 M
What is the all time high TTM FCF for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high TTM free cash flow is -$18.50 M
What is Recursion Pharmaceuticals TTM FCF year-on-year change?
Over the past year, RXRX TTM free cash flow has changed by -$40.58 M (-12.09%)